Ingevity (NYSE:NGVT) SVP Terrance Dyer Sells 496 Shares

Ingevity Corporation (NYSE:NGVT) SVP Terrance Dyer sold 496 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Ingevity Trading Down 3.0%

NGVT stock traded down $2.06 during midday trading on Monday, reaching $65.76. The company’s stock had a trading volume of 132,057 shares, compared to its average volume of 301,640. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29. The stock has a market cap of $2.29 billion, a PE ratio of -18.51 and a beta of 1.18. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The business’s 50-day simple moving average is $71.64 and its 200-day simple moving average is $65.86.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The firm had revenue of $258.00 million for the quarter, compared to analysts’ expectations of $254.73 million. During the same period last year, the firm earned $1.01 earnings per share. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, sell-side analysts expect that Ingevity Corporation will post 5.05 EPS for the current year.

Institutional Trading of Ingevity

A number of institutional investors have recently bought and sold shares of the business. Allianz Asset Management GmbH bought a new position in shares of Ingevity during the third quarter valued at about $1,670,000. CWA Asset Management Group LLC acquired a new stake in Ingevity during the fourth quarter valued at approximately $1,305,000. Harvey Partners LLC lifted its holdings in Ingevity by 5.1% during the 3rd quarter. Harvey Partners LLC now owns 601,000 shares of the company’s stock worth $33,169,000 after buying an additional 28,953 shares in the last quarter. Alpha Wave Global LP bought a new stake in shares of Ingevity in the 3rd quarter valued at $8,395,000. Finally, Allspring Global Investments Holdings LLC acquired a new position in shares of Ingevity during the 4th quarter worth about $8,083,000. Institutional investors own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on NGVT. Wells Fargo & Company lifted their price target on shares of Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. BMO Capital Markets restated an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a report on Monday, March 2nd. Wall Street Zen upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. Finally, Jefferies Financial Group restated a “buy” rating and set a $82.00 price objective on shares of Ingevity in a report on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Ingevity has a consensus rating of “Hold” and an average target price of $80.00.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.